Tags : ViewPoints Interview


ViewPoints Interview: Myovant’s Juan Camilo Arjona Ferreira Shares Insights on

In an interview with PharmaShots, Myovant’s Juan Camilo Arjona Ferreira, MD, Chief Medical Officer of Myovant Sciences shares his views on the CHMP’s positive opinion for Ryeqo (Relugolix Combination Tablet). Shots: The CHMP has adopted positive opinion recommending approval of Ryeqo (relugolix 40 mg, estradiol 1.0 mg, and norethindrone acetate 0.5 mg) for the treatment […]Read More